SecBot SecBot
SECBOTREPLAY Home › Report › SNY

SNY · The Federal Circuit affirmed the PTAB's denial of Pfizer's motion to…

Sanofi · COURT-RULING filed Jul 30, 2026 at 20:00 ET

At the news

BULLISHIMPACT 5/10

COURT-RULING filed Jul 30, 2026 at 20:00 ET

The Federal Circuit affirmed the PTAB's denial of Pfizer's motion to amend patent claims in three IPR proceedings, ruling that Pfizer's proposed substitute claims for pneumococcal vaccine patent U.S. 9,492,559 would have been obvious. This is a final win for Sanofi, removing a potential patent infringement threat to its pneumococcal vaccine franchise.

  • Federal Circuit affirmed PTAB's obviousness finding for Pfizer's proposed substitute claims 48 and 49
  • Sanofi (appellee) successfully defended against Pfizer's attempt to amend patent claims covering pneumococcal vaccine compositions
  • Ruling is nonprecedential but final, with no further appeal available
  • Patent U.S. 9,492,559 covers immunogenic compositions with specific S. pneumoniae serotypes conjugated to CRM197

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access